These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31376283)

  • 61. Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients.
    Zhang G; Man Q; Shang L; Zhang J; Cao Y; Li S; Qian R; Ren J; Pu H; Zhou J; Zhang Z; Kong W
    Acad Radiol; 2024 Jun; 31(6):2591-2600. PubMed ID: 38290884
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Establishment and Evaluation of EGFR Mutation Prediction Model Based on Tumor Markers and CT Features in NSCLC.
    Zhang H; He M; Wan R; Zhu L; Chu X
    J Healthc Eng; 2022; 2022():8089750. PubMed ID: 35422977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis.
    Chen J; Chen A; Yang S; Liu J; Xie C; Jiang H
    Radiother Oncol; 2024 Jul; 196():110325. PubMed ID: 38734145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
    Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
    Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-subtype classification model for non-small cell lung cancer based on radiomics: SLS model.
    Liu J; Cui J; Liu F; Yuan Y; Guo F; Zhang G
    Med Phys; 2019 Jul; 46(7):3091-3100. PubMed ID: 31002395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks.
    Xiong JF; Jia TY; Li XY; Yu W; Xu ZY; Cai XW; Fu L; Zhang J; Qin BJ; Fu XL; Zhao J
    Br J Radiol; 2018 Dec; 91(1092):20180334. PubMed ID: 30059241
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
    Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and validation of a model to predict tyrosine kinase inhibitor-sensitive EGFR mutations of non-small cell lung cancer based on multi-institutional data.
    Chang H; Liu YB; Yi W; Lu JB; Zhang JX
    Thorac Cancer; 2018 Dec; 9(12):1680-1686. PubMed ID: 30281214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deep learning predicts epidermal growth factor receptor mutation subtypes in lung adenocarcinoma.
    Song J; Ding C; Huang Q; Luo T; Xu X; Chen Z; Li S
    Med Phys; 2021 Dec; 48(12):7891-7899. PubMed ID: 34669994
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma.
    Li M; Li C; Ke L; Zhan M; Cheng M
    Oncol Lett; 2018 Dec; 16(6):7057-7067. PubMed ID: 30546439
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
    Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
    Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
    Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
    Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
    Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
    Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Three-dimensional topological radiogenomics of epidermal growth factor receptor Del19 and L858R mutation subtypes on computed tomography images of lung cancer patients.
    Ninomiya K; Arimura H; Tanaka K; Chan WY; Kabata Y; Mizuno S; Gowdh NFM; Yaakup NA; Liam CK; Chai CS; Ng KH
    Comput Methods Programs Biomed; 2023 Jun; 236():107544. PubMed ID: 37148668
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
    Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients.
    Liang H; Li C; Zhao Y; Zhao S; Huang J; Cai X; Cheng B; Xiong S; Li J; Wang W; Zhu C; Li W; He J; Liang W
    Cancer Manag Res; 2020; 12():8653-8662. PubMed ID: 32982456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.